Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cnfinance Holdings Ltd ADR (CNF)

Cnfinance Holdings Ltd ADR (CNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
The Big Short Squeeze: Top Performing Chinese Stocks of the Month

Fueled by a series of government stimulus measures aimed at reviving the country’s economy, Chinese stocks have surged to levels not seen in nearly two years. The rally, which has pushed Hong Kong’s...

XPEV : 11.52 (+2.58%)
BEKE : 22.09 (+0.73%)
ATGL : 9.43 (+7.04%)
OCFT : 2.63 (+1.16%)
TIGR : 6.48 (+1.89%)
BIDU : 90.02 (-1.33%)
LU : 2.61 (-2.61%)
WB : 8.96 (-0.99%)
LX : 3.20 (+0.79%)
HLPPY : 4.2555 (+3.04%)
PDD : 120.56 (-0.02%)
BZ : 14.66 (+0.76%)
CNFinance Announces Second Quarter and First Half of 2023 Unaudited Financial Results

/PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced...

CNF : 1.0500 (-1.87%)
CNFinance to Report Second Quarter and First Half of 2023 Financial Results on Tuesday, August 29, 2023

/PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced...

CNF : 1.0500 (-1.87%)
CNFinance Announces First Quarter 2023 Unaudited Financial Results

/PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced...

CNF : 1.0500 (-1.87%)
CNFinance to Report First Quarter of 2023 Financial Results on Friday, May 26, 2023

/PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced...

CNF : 1.0500 (-1.87%)
CNFinance to hold Annual General Meeting on June 8, 2023

/PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced...

CNF : 1.0500 (-1.87%)
CNFinance Files Annual Report on Form 20-F for Fiscal Year 2022

/PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced...

CNF : 1.0500 (-1.87%)
CNFinance Announces Fourth Quarter 2022 and Fiscal Year 2022 Unaudited Financial Results

/PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced...

CNF : 1.0500 (-1.87%)
CNFinance to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Wednesday, March 22, 2023

/PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced...

CNF : 1.0500 (-1.87%)
CNFinance Announces Third Quarter of 2022 Unaudited Financial Results

/PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced...

CNF : 1.0500 (-1.87%)

Barchart Exclusives

Thanks to Wall Street, Novo Nordisk Stock is Now a Buy
Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a valuation a third cheaper than competitor, Eli Lilly. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar